Aware, Inc. (AWRE) stock prices updated...
 

Aware, Inc. stock price, AWRE

Aware, Inc. stock chart:



Aware, Inc. close price: 4.9

Stock price forecast:

UP TO +14.08%
Target: 5.59

Total forecasts: 90
Reached: 77 (85.56%)

Total Win: 20.05 (330.29%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90917885.71%20.303.68%66.25-2.55-3.85%17.753.31%
30311858.06%5.342.82%66.25-2.55-3.85%2.791.58%
1415213.33%0.710.81%66.25-2.55-3.85%-1.84-2.36%
7800.00%0.000.00%40.95-1.75-4.27%-1.75-4.27%

Showing 1-10 of 480 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-02-215.25.70000-00-00
2017-02-205.25.680000-00-00
2017-02-195.25.560000-00-00
2017-02-185.25.570000-00-00
2017-02-175.055.530000-00-00
2017-02-1655.560000-00-00
2017-02-155.15.60000-00-00
2017-02-1455.580000-00-00
2017-02-135.15.440000-00-00
2017-02-125.15.320000-00-00

Aware, Inc. latest news:


  • 02/13/2017 19:09:11

    Court-Ordered Sale of TransPerfect Translation Company Is Upheld

    A Delaware court affirmed a ruling stemming from a deadlock over the management of the privately held, New York-based business its feuding founders started in a college dorm room.

  • 02/13/2017 15:05:01

    Delaware Supreme Court upholds forced company sale

    Delaware's Supreme Court has upheld the court-ordered sale of a successful New York-based translation company after a judge concluded the relationship between the company's two co-founders and sole directors had devolved into "complete dysfunction."

  • 02/05/2017 22:18:05

    BRIEF-Eastern Outfitters files for chapter 11 bankruptcy

    * Eastern Outfitters Llc files for chapter 11 bankruptcy protection in Delaware court; lists assets and liabilities in $100-$500 million range - Court filing

  • 01/30/2017 17:15:18

    Teva shares fall as court invalidates patent infringement claims

    Teva Pharmaceutical Industries Ltd. shares fell in the extended session Monday after a court did not uphold patent infringement claims made by the company. Teva shares fell 10% to $31 after hours. The court sided with Mylan NV , which claimed the patents in question were invalid. Mylan shares rose 0.7% to $36.60. The ruling from the U.S. District Court for the District of Delaware stated that the patents in contention, those covering Teva's multiple sclerosis treatment Copaxone, were not valid. Teva said it plans to appeal the decision. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/24/2017 15:39:20

    Tesco faces new legal action over accounting scandal

    Britain's biggest retailer Tesco PLC (TSCDF) is facing a new claim for damages from an investor about its 2014 profit overstatement, the company said on Tuesday. A spokesman for the supermarket group said it was aware of a claim filed by Manning & Napier, the U.S. fund manager, and would be filing a defense shortly. Manning & Napier declined to comment.

  • 01/24/2017 15:38:49

    UPDATE 2-Nortel cleared to end bankruptcy, distribute $7 bln to creditors

    WILMINGTON, Del., Jan 24 (Reuters) - Judges in Delaware and Canada approved on Tuesday a plan to pay more than $7 billion to creditors of Nortel Networks, ending years of litigation over the former telecommunications company that filed for bankruptcy in 2009.

  • 01/06/2017 10:26:32

    Tech Tip: Managing Your Passwords With a Web Browser

    Most modern browsers include a tool to save your website passwords, but be aware of potential security risks.

  • 12/15/2016 15:35:21

    Gilead shares slip as jury sides with Merck in patent lawsuit

    Shares of Gilead Sciences Inc. slipped while Merck & Co. rose in the extended session Thursday after a jury awarded Merck billions in royalties over a hepatitis C drug dispute. In a patent lawsuit against Gilead, a federal jury in Delaware awarded Merck $2.54 billion in royalties over Gilead's Sovaldi and Harvoni hepatitis C drugs, according to Reuters. Gilead shares fell 1.9% to $74.12, while Merck shares advanced 1.2% to $63.10 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/14/2016 16:16:26

    Mondelez unaware of any Kraft Heinz approach: sources

    (Reuters) - Mondelez International Inc has not heard from Kraft Heinz Co about any potential acquisition, people familiar with the matter said on Wednesday, after Swiss magazine Bilanz reported...

  • More trends:

    Axcelis Technologies, Inc.ACLS | Axion Power International, Inc.AXPW | Axion Power International, Inc.AXPWW | AxoGen, Inc.AXGN | AXT IncAXTI | B Communications Ltd.BCOM | B. Riley Financial, Inc.RILY | B.O.S. Better Online SolutionsBOSC | B/E Aerospace, Inc.BEAV | Baidu, Inc.BIDU-9.66% |